Laila A A Ramadan

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Epidermal Growth Factor Receptor

Benign Prostatic Hyperplasia

Lower Urinary Tract Symptoms

Nitric Oxide Synthase

Top Venues

Inflammopharmacology

Journal of biochemical and molecular toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Maha M Abdel-Fattah, Mohammed E Abo-El Fetoh, Hassan Afify, Laila A A Ramadan, Wafaa R Mohamed
Probenecid ameliorates testosterone-induced benign prostatic hyperplasia: Implications of PGE-2 on ADAM-17/EGFR/ERK1/2 signaling cascade. Journal of biochemical and molecular toxicology (2023)
Mohammed E Abo-El Fetoh, Maha M Abdel-Fattah, Wafaa R Mohamed, Laila A A Ramadan, Hassan Afify
Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia. Inflammopharmacology 31 (1) (2022)
Mohammed E Abo-El Fetoh, Maha M Abdel-Fattah, Wafaa R Mohamed, Laila A A Ramadan, Hassan Afify
Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia. Inflammopharmacology (2022)
Mohammed E Abo-El Fetoh, Maha M Abdel-Fattah, Wafaa R Mohamed, Laila A A Ramadan, Hassan Afify
Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia. Inflammopharmacology 31 (1) (2022)
Mohammed E Abo-El Fetoh, Maha M Abdel-Fattah, Wafaa R Mohamed, Laila A A Ramadan, Hassan Afify
Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia. Inflammopharmacology 31 (1) (2022)
Mohammed E Abo-El Fetoh, Maha M Abdel-Fattah, Wafaa R Mohamed, Laila A A Ramadan, Hassan Afify
Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia. Inflammopharmacology 31 (1) (2022)
Mohammed E Abo-El Fetoh, Maha M Abdel-Fattah, Wafaa R Mohamed, Laila A A Ramadan, Hassan Afify
Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia. Inflammopharmacology 31 (1) (2022)